glp-1 kidney Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists GLP-1 Receptor Agonists and Diabetic

Mild GI side effects are common but manageable

Autoimmune Diseases Pose a Threat to the Heart

Native amylin is co-secreted with insulin by pancreatic beta cells and promotes satiety, slowed gastric emptying, and reduced postprandial glucagon

Proponents suggest that lower doses may confer benefits whilst minimising adverse effects, though this approach remains experimental and is not supported by current regulatory approvals

SURMOUNT-5 was the head-to-head trial against semaglutide (the active ingredient in Wegovy and Ozempic)

Also, the sample size corresponded to previous studies performed with a similar protocol, which included 12-16 participants ( 3 , 4 )